progen pharmaceuticals ltd
(PGL:Australian Stock Exchange Ltd)
Leslie Tillack BSc BE (Chem)
Chief Executive Officer of PharmaSynth Pty Ltd, Progen Pharmaceuticals Limited
|Age||Total Calculated Compensation||This person is connected to 5 board members in 1 different organizations across 2 different industries.|
See Board Relationships
As of Fiscal Year 2014
Mr. Leslie Tillack, also known as Les, BSc, BE (Chem) has been the Chief Executive Officer of PharmaSynth Pty Ltd since 2008. at Progen Pharmaceuticals Limited. Mr. Tillack has been with Progen Pharmaceuticals for 11 years, overseen Progen's anti cancer drug PI-88s progression from preclinical to phase 3 manufacture and has also been responsible for the tech transfer and manufacture of many client products for both clinical applications and marketed products. Prior to ...
2806 Ipswich RoadPhone: 61 7 3273 9133
Darra, Queensland 4076
Fax: 61 7 3375 1168
Board Members Memberships*
Chief Executive Officer and Director
Education*There is no Education data available.
|There is no Competitor Compensation data available.|